Detailed deletion mapping at chromosome 9p21 in non-small cell lung cancer by microsatellite analysis and fluorescencein situ hybridization
Open Access
- 6 December 1997
- journal article
- Published by Wiley in International Journal of Cancer
- Vol. 74 (6), 588-592
- https://doi.org/10.1002/(sici)1097-0215(19971219)74:6<588::aid-ijc5>3.0.co;2-q
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Expression of Hel‐N1 and HeL‐N2 in small‐cell lung carcinomaAnnals of Neurology, 1996
- Frequency of homozygous deletion at p16/CDKN2 in primary human tumoursNature Genetics, 1995
- Importance of Chromosome 9p Loss in Human Lung CancerJNCI Journal of the National Cancer Institute, 1995
- Construction of a 2.8-megabase yeast artificial chromosome contig and cloning of the human methylthioadenosine phosphorylase gene from the tumor suppressor region on 9p21.Proceedings of the National Academy of Sciences, 1995
- 5′ CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16/CDKN2/MTS1 in human cancersNature Medicine, 1995
- Autoantibodies against the Hel-N1 RNA-binding protein among patients with lung carcinoma: An association with type I anti-neuronal nuclear antibodiesAnnals of Neurology, 1994
- Rates of p16 ( MTS1 ) Mutations in Primary Tumors with 9p LossScience, 1994
- A Cell Cycle Regulator Potentially Involved in Genesis of Many Tumor TypesScience, 1994
- Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancersNature, 1994
- Application of Confocal Laser Scanning Microscope on Fluorescence in situ Hybridization (FISH).ACTA HISTOCHEMICA ET CYTOCHEMICA, 1993